How a drug called MMRi62 kills medulloblastoma cells in the lab
Original title: MMRi62 induces iron depletion-driven apoptosis through a ferritin-independent mechanism
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was only done in cells and lab-grown tissue, not in people.
The short version
In lab tests, a drug killed brain tumor cells by taking away their iron.
What was studied. Scientists tested a drug called MMRi62 on medulloblastoma cells in the lab. They also tested it on tumor-like growths made from brain cells.
What they found. The drug killed two kinds of medulloblastoma cells and the lab-grown tumors. Researchers had thought it worked one way, but it did not. It lowered the iron inside the cells instead, and that is what killed them.
What this means, and what it doesn't
What it could mean: This helps scientists understand how the drug works. Iron inside tumor cells may be a weak spot to aim at. That is useful for planning future research.
What it doesn't mean: This does not mean there is a new treatment for medulloblastoma. The work was done in cells and lab-grown tissue, not in people. No one has tested this drug in patients with this tumor. It is far from everyday care, and it is not a promise of a cure.
Source: bioRxiv (preprint), September 23, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.